Cargando…
Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy
BACKGROUND: Beta-adrenergic antagonists or blockers (BB) are a cornerstone of cardiac therapy for multiple indications. However, BB are considered relatively contraindicated in amyloid cardiomyopathy due to poor tolerance. This intolerance is hypothesized to be due to concomitant neuropathy and sign...
Autores principales: | Ramsell, Stuart, Arias Bermudez, Carlos, Takem Baiyee, Cyril Ayuk Mbeng, Rodgers, Brandon, Parikh, Samir, Almaani, Salem, Sharma, Nidhi, LoRusso, Samantha, Freimer, Miriam, Redder, Elyse, Bumma, Naresh, Vallkati, Ajay, Efebera, Yvonne, Kahwash, Rami, Campbell, Courtney M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309481/ https://www.ncbi.nlm.nih.gov/pubmed/35898273 http://dx.doi.org/10.3389/fcvm.2022.907597 |
Ejemplares similares
-
Multidisciplinary amyloidosis care in the era of personalized medicine
por: Bumma, Naresh, et al.
Publicado: (2022) -
AL Amyloidosis: The Effect of Maintenance Therapy on Autologous Stem Cell Transplantation Outcomes
por: Ozga, Michael, et al.
Publicado: (2020) -
AL amyloidosis: The effect of fluorescent in situ hybridization abnormalities on organ involvement and survival
por: Ozga, Michael, et al.
Publicado: (2020) -
Daratumumab in Patients With Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits
por: Almaani, Salem, et al.
Publicado: (2021) -
Multiple Myeloma: Clinical Updates from the American Society of Clinical Oncology Annual Scientific Symposium 2020
por: Devarakonda, Srinivas, et al.
Publicado: (2020)